Global Synthetic Biology Market Size Likely to Surpass at a CAGR of 25% By 2034

Synthetic Biology Market Size

Global Synthetic Biology Market size is calculated at USD 28.23 Billion in 2025 and is expected to reach around USD 150.93 Billion by 2034, growing at a CAGR of 25% over the forecast period 2025 - 2034.

Synthetic Biology Market Growth Factors

The COVID-19 proliferation has led to an increase in the utilization of synthetic biology products over the past two years. Many major pharmaceutical and biotechnology companies and synthetic biology industry actors have expanded their research efforts globally by incorporating novel methods for developing test kits, treatments, and vaccines for COVID-19.

A report from the European Parliament identifies synthetic biology as one of the emergent technologies. It may be implemented in the ongoing battle against COVID-19. The National Institute of Health in the United States has also emphasized the utilization of synthetic biology as a method to expedite the development of vaccines.

It is anticipated that the global market will experience an increase as a result of the expansion of research and development initiatives in a variety of disciplines. To enhance conventional biofuel production, players are employing synthetic biology techniques to enhance performance and increase the utilization of low-cost inputs, such as refuse.

For example, fashion companies such as Modern Meadow, Bolt Threads, and Vitro Labs employ biotechnology to develop sustainable materials.

The industry witnessed substantial investments from corporate and public partnerships. According to data released by SynBioBeta, the synthetic biology sector's businesses raised 7.8 billion in investment in 2020 and 18.0 billion in 2021. DNA Script and Arbor Biotechnologies raised approximately 215 million and 167.2 million dollars, respectively.

The substantial expenditure facilitates the movement of funds through the market and facilitates the growth of businesses throughout the supply chain.

Synthetic Biology Market Drivers of Growth

• Synthetic biology is a rapidly expanding field that integrates engineering, biology, and computer science principles to develop novel biological systems and modify existing ones. A number of critical factors, such as the growing emphasis on precision medicine, the development of gene editing technologies, and the increasing demand for renewable energy sources, drive the market for synthetic biology.

• The necessity for renewable energy sources is one of the primary factors that is propelling the synthetic biology market. With the depletion of traditional energy sources and concerns regarding climate change, there is an increasing demand for alternative energy sources, including biofuels. Investment and research in the field are expected to increase due to synthetic biology's ability to engineer microorganisms to produce biofuels more efficiently and sustainably.

• The synthetic biology market is also stimulated by the advancement of gene editing technologies, including CRISPR/Cas9. These technologies enable the precise modification of an organism's genome, which can be employed to develop new functions or characteristics. It resulted in a surge in interest in genetic engineering and gene therapy, with the potential for synthetic biology to transform biotechnology and medicine.

• There is also a propelling force behind the synthetic biology market: precision medicine, which has the potential to create personalized disease treatments. Synthetic biology can assist in the development of more effective and targeted therapies with fewer adverse effects by engineering biological systems to target specific cells or tissues.

Report Scope

Synthetic Biology Market Opportunities

• A €40 million fund that targets a niche that is even more specialized than "climate tech" was unveiled by Nucleus Capital in November 2024. It endeavors to provide assistance to organizations that employ synthetic biology to reevaluate industrial or agricultural production.

• Imperial aims to forge new, investment-ready partnerships between educators and business professionals involved in Engineering Biology in November 2024, with the assistance of £3 million in funding from UK Research and Innovation (UKRI).

• Ankur Capital, Campus Fund, and other investors contributed $1.5 million to the early round of synthetic biology firm D-Nome in January 2023. The objective of D-Nome's device-less PCR technology is to democratize molecular diagnostics.
• Today, Asimov, a synthetic biology startup that develops instruments for the design of biological systems, secured $200 million in new investment in January 2023. Asimov plans to allocate the funds to expand its operations in RNA, cell/gene treatments, and biologics instruments and services.

List of the prominent players in the Synthetic Biology Market:

• Genentech Inc. (U.S.)
• Sorenson Genomics LLC (U.S.)
• Abbott Molecular (U.S.)
• Bayer Diagnostics (U.S.)
• Genomic Health (U.S.)
• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• Agilent Technologies (US)
• Novozymes (Denmark)
• Ginkgo Bioworks (US)
• Amyris (US)
• Precigen Inc. (US)
• GenScript (China)
• Twist Bioscience (US)
• Synthetic Genomics (US)
• Codexis Inc. (US)
• Synthego (US)
• Creative Enzymes (US)
• Eurofins Scientific (Luxembourg)
• Bota Biosciences Inc. (China)
• Creative Biogene (US)
• Enbiotix Inc. (US)
• Illumina Inc. (US)
• New England Biolabs (US)
• Pareto Bio Inc. (US)
• Others

The Synthetic Biology Market is segmented as follows:

By Tool

• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Synthetic Cells
• Chassis Organisms
• Xeno-Nucleic Acids

By Application

• Medical Application
• Pharmaceuticals
• Drug Discovery and Therapeutics
• Artificial Tissue and Tissue Regeneration
• Industrial Applications
• Food & Agriculture
• Environmental Applications

By Technology

• Gene Synthesis
• Genome Engineering
• Sequencing
• Bioinformatics
• Site-directed Mutagenesis
• Cloning
• Measurement and Modelling
• Microfluidics
• Nanotechnology

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America